APA (7th ed.) Citation

L, Z., YQ, L., SW, H., H, X., R, Z., K, C., . . . HY, W. (2025). The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. Neuro-oncology, 27(2), 492. https://doi.org/10.1093/neuonc/noae175

Chicago Style (17th ed.) Citation

L, Zeng, et al. "The Deubiquitinase USP44 Enhances Cisplatin Chemosensitivity Through Stabilizing STUB1 to Promote LRPPRC Degradation in Neuroblastoma." Neuro-oncology 27, no. 2 (2025): 492. https://doi.org/10.1093/neuonc/noae175.

MLA (9th ed.) Citation

L, Zeng, et al. "The Deubiquitinase USP44 Enhances Cisplatin Chemosensitivity Through Stabilizing STUB1 to Promote LRPPRC Degradation in Neuroblastoma." Neuro-oncology, vol. 27, no. 2, 2025, p. 492, https://doi.org/10.1093/neuonc/noae175.